3/20/2024 | 39123900 | PHARMACEUTICAL RAW MATERIAL FOR PHARMACEUTICAL INDUSTRY
SURELEASE ETHYLCELLULOSE DISPERSION TYPE B NF CLEAR DRAP CLEARANCE CERTIFICATE NO. E-8657448023162 DATED 13.03.2024 | XXXXXXXXXX | 108 | KG | 8856.302943 | USA | LPAF |
9/13/2023 | 39123900 | PHARMACEUTICAL RAW MATERIAL FOR PHARMACEUTICAL INDUSTRY
SURELEASE ETHYLCELLULOSE DISPERSION TYPE B NF CLEAR DRAP CLEARANCE CERTIFICATE NO. E-6323048021653 DATED 29.08.2023. | XXXXXXXXXX | 108 | KG | 8926.450755 | USA | LPAF |
8/9/2023 | 39123900 | PHARMACEUTICAL RAW MATERIAL
SURELEASE ETHYLCELLULOSE DISPERSION TYPE B NF CLEAR USP/NF (DRAP CLEARANCE CERTIFICATE NO:E-6146364237913 DATED: 03-08-2023) | XXXXXXXXXX | 306 | KG | 14778.259961 | USA | KPAF |
5/3/2023 | 39129000 | PHARMACEUTICAL RAW MATERIAL SURELEASE ETHYLCELLULOSE DISPERSION TYPE B NF CLEAR (ADC NO E-5003059936239 DT 10.4.2023) | XXXXXXXXXX | 306 | KG | 15128.64 | USA | KPAF |
4/7/2023 | 39123900 | PHARMACEUTICAL RAW MATERIAL FOR PHARMACEUTICAL INDUSTRY
SURELEASE ETHYLCELLULOSE DISPERSION TYPE B NF CLEAR DRAP CLEARANCE CERTIFICATE NO. E-4840362828157 DATED 29.03.2023 | XXXXXXXXXX | 108 | KG | 8699.4 | USA | LPAF |